Articles

1. Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study

   • Dagoberto Serpa-Díaz
   • Carlos A. Llanos-Florez
   • Maria A. Alzate-Vinasco

   Original Research Open access 30 April 2024

   

2. Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis

   • Rachel S. Newson
   • Victoria Divino
   • Julie E. Mount

   Original Research Open access 29 April 2024

   

3. Podcast on the IWGDF 2023 Guidelines on the Prevention of Foot Ulcers in Persons with Diabetes

   • Sicco A. Bus
   • Jaap J. Van Netten

   Commentary Open access 26 April 2024

4. An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy

   • Francesco Saverio Mennini
   • Paolo Sciattella
   • Ugo Trama

   Original Research Open access 26 April 2024

   

5. Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review

   • Omnia Azmy Nabeh
   • Alaa Amr
   • Soha Aly Elmorsy

   Review Open access 26 April 2024

   

6. Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump

   • Terri Jerkins
   • Katherine Stockham
   • David S. H. Bell

   Case Report Open access 24 April 2024

   

7. Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)

   • Masahiro Fukuda
   • Ichiro Sakuma
   • on behalf of the J-SELECT study investigators

   Original Research Open access 24 April 2024

8. The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol

   • Peter Novodvorský
   • Lenka Thieme
   • Martin Haluzík

   Study Protocol Open access 24 April 2024

   

9. Correction to: Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD

   • Giuseppina Guarino
   • Felice Strollo
   • Sandro Gentile

   Correction Open access 22 April 2024

   

10. Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years

    • Daniel Tajdar
    • Dagmar Lühmann
    • Ingmar Schäfer

    Original Research Open access 20 April 2024

    

11. Psychosocial Self-efficacy and its Association with Selected Potential Factors Among Adults with Type 1 Diabetes: A Cross-Sectional Survey Study

    • Divya Anna Stephen
    • Anna Nordin
    • Jan Nilsson

    Original Research Open access 20 April 2024

    

12. Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study

    • Pierre Gourdy
    • Patrice Darmon
    • Alfred Penfornis

    Original Research Open access 20 April 2024

    

13. Real-World Effectiveness of the Gla-300 + Cap + App Program in Adult Users Living with Type 2 Diabetes in Taiwan

    • Chih-Yuan Wang
    • Fang L. Zhou
    • Jung-Fu Chen

    Original Research Open access 20 April 2024

    

14. Correction to: Use of IDegLira to Intensify, Simplify, and Increase Appropriateness of Type 2 Diabetes Therapy: A Real-Life Experience

    • Isabella Romano
    • Rosalia Serra

    Correction Open access 18 April 2024

15. Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia–Pacific Region

    • Roger Chen
    • Azizul Hasan Aamir
    • Roopa Mehta

    Review Open access 16 April 2024

    

16. Neutrophil Extracellular Traps (NETs) Are Associated with Type 2 Diabetes and Diabetic Foot Ulcer Related Amputation: A Prospective Cohort Study

    • Irshat Ibrahim
    • Yilimire Nuermaimaiti
    • Yuanquan Wu

    Original Research Open access 15 April 2024

    

17. Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study

    • Chiara Di Loreto
    • Roberta Celleno
    • Paola Del Sindaco

    Original Research Open access 11 April 2024

    

18. Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study

    • Björn Eliasson
    • Elin Allansson Kjölhede
    • Katarina Eeg-Olofsson

    Original Research Open access 10 April 2024

    

19. Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus

    • Yujie Zhang
    • Xiao Yin
    • Xindao Yin

    Original Research Open access 05 April 2024 Pages: 1215 - 1229

    

20. SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review

    • Samuel Seidu
    • Vicki Alabraba
    • John P. H. Wilding

    Review Open access 05 April 2024 Pages: 1099 - 1124

    

21. Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial

    • Lori M. Laffel

    Summary of Research Open access 05 April 2024 Pages: 893 - 896

    

22. Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)

    • Tamiko Tamanaha
    • Hisashi Makino
    • Kiminori Hosoda

    Study Protocol Open access 04 April 2024 Pages: 1245 - 1254

    

23. An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D)

    • Kevin M. Pantalone
    • Bruce Rogen
    • Bartolome Burguera

    Original Research Open access 04 April 2024 Pages: 1201 - 1214

    

24. The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review

    • Janet B. McGill
    • Irl B. Hirsch
    • James R. Gavin III

    Review Open access 04 April 2024 Pages: 1085 - 1098

25. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    • Robert M. Gutgesell
    • Rubén Nogueiras
    • Timo D. Müller

    Review Open access 04 April 2024 Pages: 1069 - 1084

    

26. Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study

    • Akiko Takahashi
    • Manabu Ishii
    • Makoto Kunisaki

    Original Research Open access 30 March 2024 Pages: 1187 - 1199

    

27. Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity

    • Klara R. Klein
    • Trine J. Abrahamsen
    • on behalf of the N3C Consortium

    Original Research Open access 27 March 2024 Pages: 1169 - 1186

    

28. Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes

    • Anu Gupta
    • Alpesh Goyal
    • Yashdeep Gupta

    Original Research Open access 23 March 2024 Pages: 1155 - 1168

    

29. Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis

    • Esteban J. Gimeno
    • Mette Bøgelund
    • Domingo Orozco-Beltran

    Review Open access 23 March 2024 Pages: 1047 - 1067

    

30. The Why, What and Where Podcast on the Updated 2023 IWGDF Guideline on Offloading Treatments for Diabetes-Related Foot Ulcers

    • Sicco A. Bus
    • Peter A. Lazzarini

    Commentary Open access 23 March 2024

31. Podcast on How to Classify Foot Ulcers in People with Diabetes (2023 Update of the IWGDF Guidelines on Classification)

    • Matilde Monteiro-Soares
    • Fran Game

    Commentary Open access 21 March 2024

32. Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial

    • Xiaxuan Zhu
    • Li Xia
    • Rui Wei

    Study Protocol Open access 18 March 2024 Pages: 1231 - 1244

    

33. Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study

    • Sakiko Terui
    • Mari Igari
    • Jun Shirakawa

    Original Research Open access 18 March 2024 Pages: 1139 - 1153

    

34. Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups

    • Yan Bi
    • Song Lu
    • Linong Ji

    Original Research Open access 18 March 2024 Pages: 1125 - 1137

    

35. Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design

    • Kristin Castorino
    • Beatrice Osumili
    • Carolina Piras de Oliveira

    Review Open access 18 March 2024 Pages: 929 - 1045

    

36. The Implication of Diabetes-Specialized Nurses in Aiming for the Better Treatment and Management of Patients with Diabetes Mellitus: A Brief Narrative Review

    • Yefang Zhu
    • Hongmei Zhang
    • Hong Lei

    Review Open access 12 March 2024 Pages: 917 - 927

37. Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel

    • Adam G. Tabak
    • Peter Kempler
    • Boris Mankovsky

    Review Open access 12 March 2024 Pages: 897 - 915

38. Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT)

    • Weimin Wang
    • Xiangyun Chang
    • Dalong Zhu

    Original Research Open access 05 March 2024 Pages: 725 - 739

    

39. Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study

    • Sharmistha Roy Chowdhury
    • Fethi Sadouki
    • Stephen C. Bain

    Brief Report Open access 01 March 2024 Pages: 869 - 881

    

40. Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study

    • Meredith Hoog
    • Juan M. Maldonado
    • Manige Konig

    Original Research Open access 01 March 2024 Pages: 855 - 867

    

41. Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study

    • Amy L. McKenzie
    • Shaminie J. Athinarayanan

    Original Research Open access 29 February 2024 Pages: 843 - 853

    

42. Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model

    • Hiroaki Iijima
    • Hidetoshi Shimizu
    • Takashi Kadowaki

    Publisher Correction Open access 29 February 2024 Pages: 779 - 780

43. Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis

    • Jonathan Y. M. Lai
    • David R. Riley
    • Uazman Alam

    Original Research Open access 24 February 2024 Pages: 833 - 842

    

44. Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist

    • Xiaosu Ma
    • Rong Liu
    • Kyle W. Sloop

    Original Research Open access 24 February 2024 Pages: 819 - 832

    

45. Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study

    • Kazuo Hara
    • Tetsuaki Hirase
    • Ryo Takemura

    Original Research Open access 24 February 2024 Pages: 801 - 817

    

46. Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

    • Yuying Cui
    • Jinming Yao
    • Lin Liao

    Original Research Open access 24 February 2024 Pages: 781 - 799

    

47. Personalized Versus Non-personalized Nutritional Recommendations/Interventions for Type 2 Diabetes Mellitus Remission: A Narrative Review

    • Ana T. Arias-Marroquín
    • Fabiola M. Del Razo-Olvera
    • Carlos A. Aguilar-Salinas

    Review Open access 20 February 2024 Pages: 749 - 761

    

48. Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan

    • Daisuke Yabe
    • Munehide Matsuhisa
    • Yasuo Terauchi

    Original Research Open access 16 February 2024 Pages: 705 - 723

    

49. Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review

    • Stavroula A. Paschou
    • Kleoniki I. Athanasiadou
    • Nikolaos Papanas

    Review Open access 16 February 2024 Pages: 741 - 748

50. Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in Japan

    • Junko Sato
    • Kenichi Nakajima
    • Hirotaka Watada

    Study Protocol Open access 15 February 2024 Pages: 883 - 892